HIV

Individuals who perceive themselves to be at a high risk of HIV are more likely to accept pre-exposure prophylaxis (PrEP) than their peers.

A prescription drug ad broadcast during the musical on television has set the stage for a larger conversation about patient access to preexposure prophylaxis medication.

Better strategies are needed to adequately identify and prevent opportunistic infections and related deaths in patients with advanced HIV.

A look at last week's top stories in the world of pharmacy.

The new indication would allow treatment-experienced patients with HIV to switch to Pifeltro in combination with other HIV medications or Delstrigo.

Through ongoing quarterly targeted medication counseling follow-up sessions, the pharmacist may identify ART noncompliance.

An overview of scientific evidence supporting the HIV undetectable=untransmittable concept and implications for HIV prevention and treatment.

Offering screening and referrals for mental health and peer support services can improve HIV outcomes in American Indian and Alaska Native patients.

People who inject drugs may not accurately self-report HIV and antiretroviral drug status when entering an HIV prevention study.

Researchers identified an immune receptor that may lead to new drug treatments that target immune activation in patients with HIV.

Top news of the week from Specialty Pharmacy Times.

A newly study published study aimed to distinguish between uninfected cells and latently infected cells, with hopes that eradicating the latent reservoirs could lead to a cure for the disease.

Community-acquired pneumonia is a major cause of mortality and morbidity among patients with HIV.

Controlling the viral reaction of cells latently infected with HIV may have implications for future drug treatments.

Researches seeking to eliminate HIV are close enough to see the finish line, but with no idea how far away they are from a cure.

Drug approvals and emerging research highlighted the news in the HIV space this past year.

Foreign-born black women aren’t benefiting from HIV prevention programs at the same rates as other women.

For men living with HIV, stigma associated with the disease may be directly related to cognitive impairment and everyday functioning

Understanding how HIV-related stigma can affect patients later in life can lead to new approaches to address cognitive impairment in this population.

In a 2-part study, a research team with Desert Regional Medical Center in Corona, CA is analyzing the need for pharmacist intervention for patients with HIV.

Cheyenne Newsome, PharmD, PhC, BCACP, clinical assistant professor at the Washington State University College of Pharmacy, discusses the health disparities seen in the LGBTQ community and what considerations providers should keep in mind when treating transgender patients.

HIV is not associated with preterm delivery, though antiretroviral therapy is, but hepatitis C may be a potential risk factor.

While scientists know more about the HIV infection than ever, and can prevent it from progressing into AIDS, there is still no known cure for the virus.

A look at last week's top stories in the world of pharmacy.

New platform would allow health care providers in developing nations to perform easy HIV testing and monitoring.

The Task Force notes in the draft recommendations that clinicians should screen everyone between the ages 15 to 65 years and all pregnant women for HIV.

Fostemsavir (ViiV Healthcare) may be a potential new option for patients with HIV who have become resistant to other medications.

New recommendations urge health care providers to offer pre-exposure prophylaxis (PrEP) to individuals at high risk of HIV.

Antiretroviral drug treatment was not found to be a cause of the higher prevalence of hypertension in persons infected with HIV.

Cellular proliferation predominantly drives HIV persistence on antiretroviral therapy, according to a new study.